Back to Journals » Biologics: Targets and Therapy

Biologics: Targets and Therapy

ISSN: 1177-5491


ISSN: 1177-5475 (Print) - went to online only in 2009

An international, peer reviewed journal focusing on the patho-physiological rationale for, and clinical application of, Biologic agents and their Biosimilars in the management of autoimmune diseases, cancers, or other pathologies where a molecular target can be identified.


This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

 

 

 

  

 

 

Latest articles:

- 5 records -

MDMX in Cancer: A Partner of p53 and a p53-Independent Effector

Lin W, Yan Y, Huang Q, Zheng D

Biologics: Targets and Therapy 2024, 18:61-78

Published Date: 31 January 2024

Advances with Platelet-Rich Plasma for Bone Healing

Bacevich BM, Smith RDJ, Reihl AM, Mazzocca AD, Hutchinson ID

Biologics: Targets and Therapy 2024, 18:29-59

Published Date: 25 January 2024

Recent Advancements in Reducing the Off-Target Effect of CRISPR-Cas9 Genome Editing

Asmamaw Mengstie M, Teshome Azezew M, Asmamaw Dejenie T, Teshome AA, Tadele Admasu F, Behaile Teklemariam A, Tilahun Mulu A, Mekonnen Agidew M, Adugna DG, Geremew H, Abebe EC

Biologics: Targets and Therapy 2024, 18:21-28

Published Date: 18 January 2024

Effect of N-Acetylcysteine on Cisplatin Toxicity: A Review of the Literature

Zavala-Valencia AC, Velasco-Hidalgo L, Martínez-Avalos A, Castillejos-López M, Torres-Espíndola LM

Biologics: Targets and Therapy 2024, 18:7-19

Published Date: 16 January 2024

Successful Response to Golimumab in a Case of Relapsing Polychondritis Overlapping with Ulcerative Colitis

Kojima S, Matsumoto S, Koito Y, Miura T, Sekine M, Uehara T, Asano T, Yamaguchi Y, Mashima H

Biologics: Targets and Therapy 2024, 18:1-6

Published Date: 12 January 2024


Read more articles